Market open
Inogen/$INGN
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Inogen
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
Ticker
$INGN
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
834
Website
Inogen Metrics
BasicAdvanced
$234M
-
-$2.24
1.03
-
Price and volume
Market cap
$234M
Beta
1.03
52-week high
$12.91
52-week low
$5.82
Average daily volume
278K
Financial strength
Current ratio
2.66
Quick ratio
2.153
Long term debt to equity
9.369
Total debt to equity
10.867
Management effectiveness
Return on assets (TTM)
-9.66%
Return on equity (TTM)
-25.33%
Valuation
Price to revenue (TTM)
0.698
Price to book
1.26
Price to tangible book (TTM)
1.65
Price to free cash flow (TTM)
-15.993
Growth
Revenue change (TTM)
1.12%
Earnings per share change (TTM)
-60.95%
3-year revenue growth (CAGR)
-2.31%
3-year earnings per share growth (CAGR)
64.61%
What the Analysts think about Inogen
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Inogen stock.
Inogen Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Inogen Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Inogen News
AllArticlesVideos
Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell
Business Wire·4 weeks ago
Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
Business Wire·1 month ago
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Inogen stock?
Inogen (INGN) has a market cap of $234M as of February 25, 2025.
What is the P/E ratio for Inogen stock?
The price to earnings (P/E) ratio for Inogen (INGN) stock is 0 as of February 25, 2025.
Does Inogen stock pay dividends?
No, Inogen (INGN) stock does not pay dividends to its shareholders as of February 25, 2025.
When is the next Inogen dividend payment date?
Inogen (INGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Inogen?
Inogen (INGN) has a beta rating of 1.03. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.